# Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer

> **NCT07272382** · NA · RECRUITING · sponsor: **Fudan University** · enrollment: 142 (estimated)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** PD-1 + Omega-3 Fatty Acids (EPA/DHA)
- **DIETARY_SUPPLEMENT:** PD-1 + Placebo (Oral Drops)

## Key facts

- **NCT ID:** NCT07272382
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-05
- **Primary completion:** 2027-06-05
- **Final completion:** 2027-06-05
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272382, "Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07272382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*